Johnson & Johnson will not be undertaking local trials for its single-shot COVID-19 vaccine in India.
That's according to a report in The Economic Times on Tuesday, citing a company spokesperson.
While J&J had sought approval for conducting bridging trials in the country, the US-based drugmaker said it wouldn't have to do that now since India has scrapped that requirement,
The company is exploring how to accelerate the availability of its vaccine in India, the newspaper added.


8 Israeli airstrikes hit Syria's Abu al-Duhur airbase, state TV reports
Two killed in high school shooting in southern Philippines
Pakistan top court orders ex-PM Imran Khan be moved to hospital from jail
Russian missile attack kills 10 in Ukraine's Kharkiv region, governor says
Trump says Iran won't make deal he thinks is needed
